Disease-A-Month
Volume 52, Issue 11 , Pages 428-434 , November 2006

Treatment of Tuberculosis

References 

  1. Styblo K. Recent advances in epidemiological research in tuberculosis. Indian J Chest Dis Allied Sci. 1982;24:101–107
  2. British Medical Research Council. Treatment of pulmonary tuberculosis with para-aminosalicylic acid and streptomycin. BMJ. 1949;2:1521–1525
  3. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Monaldi Arch Chest Dis. 1994;49:327–345
  4. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994;330:1179–1184
  5. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2006;CD003343
  6. Burman WJ, Cohn DL, Rietmeijer CA, et al. Short-term incarceration for the management of noncompliance with tuberculosis treatment. Chest. 1997;112:57–62
  7. Campbell IA, Bah-Sow O. Pulmonary tuberculosis: diagnosis and treatment. BMJ. 2006;332:1194–1197
  8. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167:603–662
  9. Iseman MD. Tuberculosis therapy: past, present and future. Eur Respir J Suppl. 2002;36:87s–94s
  10. Benator D, Bhattacharya M, Bozeman L, et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet. 2002;360:528–534
  11. Zhang Y, Post-Martens K, Denkin S. New drug candidates and therapeutic targets for tuberculosis therapy. Drug Discov Today. 2006;11:21–27
  12. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351:1741–1751
  13. Blumberg HM, Leonard MK, Jasmer RM. Update on the treatment of tuberculosis and latent tuberculosis infection. JAMA. 2005;293:2776–2784

PII: S0011-5029(06)00090-3

doi: 10.1016/j.disamonth.2006.09.007

Disease-A-Month
Volume 52, Issue 11 , Pages 428-434 , November 2006

Article Tools